HLA‐G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex
- 1 August 1997
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 27 (8) , 1875-1880
Abstract
The lack of classical human histocompatibility leukocyte antigen (HLA) molecules in human placenta prevents the recognition and lysis by maternal T lymphocytes but poses the problem of susceptibility to natural killer (NK) cell‐mediated lysis. The nonclassical HLA class I molecule HLA‐G may mediate protection from NK cells. NK cells are known to express a number of HLA class I‐specific inhibitory receptors. These include members of the immunoglobulin (Ig) superfamily (p58, p70, p140), characterized by a defined allele specificity, and CD94/NKG2A with a broad specificity for different HLA class I molecules. We analyzed a series of NK cell clones derived from normal peripheral blood expressing different NK receptors (NKR). Clones were analyzed for their cytolytic activity against the HLA class I‐negative 221 cell line either untransfected or transfected with HLA‐G (221/G) or other informative alleles, as control. All clones expressing CD94/NKG2A [as identified by the Z199 monoclonal antibody (mAb)] displayed a markedly reduced cytolytic activity against 221/G. Moreover, mAb directed to the CD94/NKG2A complex completely restored target cell lysis. Among NKG2A‐negative NK clones, different functional patterns could be detected. Clones expressing inhibitory receptors belonging to the Ig superfamily lysed 221/G target cells with equal or higher efficiency than untransfected 221 cells. These data indicated that p58, p70 and p140 do not function as HLA‐G‐specific inhibitory NKR, and that HLA‐G‐specific activating NKR also exist. Further analysis indicated that in these clones (characterized by the CD94+/NKG2A− phenotype) mAb specific for CD94, but not for the other NKR, reversed the activating effect. Infrequent clones were also isolated that, in spite of the lack of CD94/NKG2A, displayed HLA‐G specificity, thus suggesting the existence of a different, still unknown NKR.Keywords
This publication has 32 references indexed in Scilit:
- CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodiesEuropean Journal of Immunology, 1996
- HLA-G revisitedImmunology Today, 1996
- CD94 and a Novel Associated Protein (94AP) Form a NK Cell Receptor Involved in the Recognition of HLA-A, HLA-B, and HLA-C AllotypesImmunity, 1996
- Immunology: Keeping mother at bayCurrent Biology, 1996
- RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLSAnnual Review of Immunology, 1996
- Nonclassical HLA-G molecules are classical peptide presentersCurrent Biology, 1996
- Antigen-presenting function(s) of the non-classical HLA-E, -F and -G class I molecules: the beginning of a storyResearch in Immunology, 1996
- Molecular characterization of human CD94: A type II membrane glycoprotein related to the C‐type lectin superfamilyEuropean Journal of Immunology, 1995
- Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones.Journal of Experimental Medicine, 1995
- Structure of the HLA class I region and expression of its resident genesCurrent Opinion in Immunology, 1993